Journal article
Low dose bleomycin and methotrexate in cervical cancer
Cancer, v 37(2), pp 660-664
Feb 1976
PMID: 56215
Abstract
Twenty patients with recurrent and disseminated carcinoma of the cervix were treated with Bleomycin, 10 mg/m2 weekly and Methotrexate, 10 mg/m2 every fourth day. Twelve of the 20 (60%) had a greater than 50% shrinking of measured tumor masses lasting a median remission time of 7.5 months. The data suggest that combination protracted chemotherapy with these drugs of metastatic cervical cancer might improve the outlook of patients with this condition.
Metrics
4 Record Views
Details
- Title
- Low dose bleomycin and methotrexate in cervical cancer
- Creators
- James F. Conroy - Hahnemann University HospitalGeorge C. Lewis - Thomas Jefferson University HospitalLuther W. Brady - Hahnemann University HospitalIsadore Brodsky - Hahnemann University HospitalSigmund B. Kahn - Hahnemann University HospitalDavid RossRobert Nuss - Hahnemann University Hospital
- Publication Details
- Cancer, v 37(2), pp 660-664
- Publisher
- Wiley Subscription Services, Inc., A Wiley Company
- Number of pages
- 5
- Grant note
- National Cancer Institute (1‐P01‐CA14043‐01A1; CA 08024) PHS (1‐R10‐CA12252) National Cancer Institute (5‐R10‐CA12478) Eastern Cooperative Oncology Group (CA 13611)
- Resource Type
- Journal article
- Language
- English
- Web of Science ID
- WOS:A1976BJ51900007
- Scopus ID
- 2-s2.0-0017290071
- Other Identifier
- 991021901006304721